Investigating the role of glutamate in glioblastoma
Official title: Role of Glutamate-mediate Excitotoxicity in Invasion and Progression Processes of Glioblastoma Multiforme
Run by IRCCS San Raffaele · NCT05775458 · Data updated 2026-11-12
This study is testing how levels of glutamate in blood and spinal fluid might affect the growth of glioblastoma in patients suspected of having this aggressive brain tumor.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | IRCCS San Raffaele Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Milan, Milan) |
| Status | Recruiting |
| Started | June 1, 2020 |
| Main results expected | November 1, 2028 |
| Study ends | September 30, 2029 |
| Registry record updated | June 11, 2025 |
| Trial ID | NCT05775458 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult patients with a brain lesion suspected to be GBM who are eligible for gross total tumor resection.
✕Probably not a fit
Patients under 18 years old, those with liver disease, severe anemia, or who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on glioblastoma multiforme (GBM), the most aggressive type of primary brain tumor. It aims to analyze the levels of glutamate and its related enzymes in serum and cerebrospinal fluid (CSF) to understand their role in tumor growth and invasion. A total of 40 patients suspected of having GBM will undergo blood sampling and MRI imaging at baseline and during follow-up at 3, 6, and 9 months. The study will collect molecular biology data alongside oncological and imaging information to explore potential therapeutic targets.
Why it matters
Potential benefit: If successful, this study could lead to new therapeutic approaches targeting glutamate signaling in glioblastoma treatment.
How similar studies have gone: While the role of glutamate in glioblastoma is being explored, this specific approach of measuring glutamate levels as biomarkers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with a brain lesion suspected for GBM, candidate to gross total tumor resection (GTR), followed by radiotherapy and chemotherapy (concomitant and adjuvant). * Patient able to provide informed consent. Exclusion Criteria: * Age \< 18 years * Liver disease * Severe anemia (Hb \<8mg/dl) * Pregnancy
Where it's running
-
IRCCS San Raffaele Scientific Institute
Milan, Milan, Italy Recruiting
Study contacts
- Study coordinator: Sincinelli Laura
- Email: sincinelli.laura@hsr.it
- Phone: 0226436658
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Focused ultrasound to open the blood-brain barrier in adults with high-grade glioma on chemotherapy
This trial tests whether focused ultrasound using the Next Generation Dome Helmet can safely open the blood-brain barrier in adults with glioblastoma who are receiving maintenance temozolomide chemotherapy.
-
High-intensity interval training to improve fitness in brain tumor patients
This study is testing if high-intensity interval training can help adults with stable brain tumors feel fitter compared to those who don't exercise.
-
Investigating brain network changes in children with brain tumors after radiation therapy
This study is trying to see how radiation therapy changes brain connections in children with brain tumors and how those changes might affect their thinking skills after treatment.
-
Characterizing immune cells in malignant brain tumors
This study is trying to understand how immune cells behave in people with malignant brain tumors by looking at their blood and tumor samples before and after surgery.
-
Collection of blood samples from adults with brain tumors
This study is collecting blood samples from adults with brain tumors to see if certain markers in the blood can help improve treatment outcomes after radiation therapy.
-
Observing the growth of non-malignant brain tumors
This study looks at how non-cancerous brain tumors grow over time in patients who don't have symptoms and aren't needing treatment, using regular MRI scans to track changes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.